LINEBURG


<< . .

 67
( 87)



. . >>

Adapted from Centers for Disease Control and Prevention. Taxonomy and classification of viruses. www.ncbi.nlm.nih.gov/ICTVdb/MCM8.pdf



may be limited to life support and/or the containment of the against disease is a helpful control measure, vaccination is not a
infectious agent. A large number of infectious agents, particularly panacea, as recent outbreaks of mumps among vaccinated young
those causing tropical disease, lead to chronic infections, often adults have shown. In infectious disease, as in anesthesiology, we
with transmission to the fetus. Unfortunately, reports detailing must be vigilant at all times.
anesthetic management of these patients are rarely published, so
the obstetric anesthesiologist must understand the pathophysio-
Acknowledgement
logy of the disease and its clinical features in order to make rational
decisions relating to anesthesia. The usual contraindications to The authors truly appreciate the contributions of Valerie Creswell,
regional anesthesia or GA should be considered. Intravenous and MD, an infectious disease expert in Wichita, Kansas. Her review
local techniques that preserve cardiorespiratory function should and critique of this chapter significantly refined the text.
be considered in high-risk patients in whom contraindications to
both regional anesthesia and GA exist.
REFERENCES
The most effective means to control infectious diseases is pre-
1. Kuczkowski, K. M. & Reisner, L. S. Anesthetic management of the parturient
vention. Spread of infectious agents is limited by good hygiene
with fever and infection. J. Clin. Anesth. 2003; 15: 478“88.
and the use of sterile precautions. Political and economic support 2. Lamont, R. F. & Sawant, S. R. Infection in the prediction and antibiotics in the
for preventive health measures including proper sanitation is prevention of spontaneous preterm labour and preterm birth. Minerva
paramount, especially in developing countries. While vaccination Ginecol. 2005; 57: 423“33.




336
Chapter 18


3. Yeo, B. K., Lim, L. P., Paquette, D. W. & Williams, R. C. Periodontal guidelines for the use of innovative therapies in sepsis. Crit. Care Med.
disease “ the emergence of a risk for systemic conditions: pre- 1992; 20: 864“74.
term low birth weight. Ann. Acad. Med. Singapore 2005; 34: 111“16. 28. Greenberg, L. R. & Moore, T. R. Staphylococcal septicemia and adult
4. Sheffield, J. S. & Cunningham, F. G. Urinary tract infection in women. respiratory distress syndrome in pregnancy treated with extracorporeal
Obstet. Gynecol. 2005; 106: 1085“92. carbon dioxide removal. Obstet. Gynecol. 1995; 86: 657“60.
5. Rouse, D. J., Goldenberg, R. L., Cliver, S. P. et al. Strategies for the prevention 29. Iseri, S. O., Sener, G., Saglam, B. et al. Oxytocin protects against sepsis-
of early-onset neonatal group B streptococcal sepsis: a decision analysis. induced multiple organ damage: role of neutrophils. J. Surg. Res. 2005;
Obstet. Gynecol. 1994; 83: 483“94. 126: 73“81.
6. Wakimoto, H., Yano, H., Baba, S. et al. Prevention of vertical transmission of 30. Xiao, H. & Remick, D. G. Correction of perioperative hypothermia decreases
Group B Streptococcus. Kansenshogaku Zasshi 2005; 79: 549“55. experimental sepsis mortality by modulating the inflammatory response.
7. Headley, J., Northstone, K., Simmons, H. & Golding, J. ALSPAC Study Team. Crit. Care Med. 2005; 33: 161“7.
Medication use during pregnancy: data from the Avon Longitudinal Study 31. Reynolds, F., Sharma, S. K. & Seed, P. T. Analgesia in labour and fetal acid-
of Parents and Children. Eur. J. Clin. Pharmacol. 2004; 60: 355“61. base balance: a meta-analysis comparing epidural with systemic opioid
8. Mazor, M., Chaim, W., Bar-David, J. et al. Prenatal diagnosis of microbial analgesia. B. J. O. G. 2002; 109: 1344“53.
invasion of the amniotic cavity with Campylobacter coli in preterm labour. 32. Adolphs, J., Schmidt, D. K., Korsukewitz, I. et al. Effects of thoracic epidural
Br. J. Obstet. Gynaecol. 1995; 102: 71“2. anaesthesia on intestinal microvascular perfusion in a rodent model of
9. Fredricks, D. N., Fiedler, T. L. & Marrazzo, J. M. Molecular identification of normotensive endotoxaemia. Intensive Care Med. 2004; 30: 2094“101.
bacteria associated with bacterial vaginosis. N. Engl. J. Med. 2005; 353: 33. Leighton, B. L. & Halpern, S. H. The effects of epidural analgesia on labor,
1899“911. maternal, and neonatal outcomes: a systematic review. Am. J. Obstet.
10. Edwards, J. L. & Apicella, M. A. The molecular mechanisms used by Gynecol. 2002; 186: S69“77.
Neisseria gonorrhoeae to initiate infection differ between men and 34. Alexander, J. M. Epidural analgesia for labor pain and its relationship to
women. Clin. Microbiol. Rev. 2004; 17: 965“81. fever. Clin. Perinatol. 2005; 32: 777“87.
11. Miller, K. E. Diagnosis and treatment of Chlamydia trachomatis infection. 35. Goetzl, L., Cohen, A., Frigoletto, F., Jr. et al. Maternal epidural use and
Am. Fam. Physician 2006; 73: 1411“16. neonatal sepsis evaluation in afebrile mothers. Pediatrics 2001; 108:
12. Wu, S., Shen, L. & Liu, G. Study on vertical transmission of Chlamydia 1099“102.
trachomatis using PCR and DNA sequencing. Chin. Med. J. (Engl.) 1999; 36. Suliburk, J. W., Helmer, K. S., Gonzalez, E. A., Robinson, E. K. & Mercer,
112: 396“9. D. W. Ketamine attenuates liver injury attributed to endotoxemia: role of
13. Rahangdale, L. Guerry, S., Bauer, H. M. et al. An observational cohort study cyclooxygenase-2. Surgery 2005; 138: 134“40.
of Chlamydia trachomatis treatment in pregnancy. Sex. Transm. Dis. 2006; 37. Yang, J., Li, W., Duan, M. et al. Large dose ketamine inhibits
33: 106“10. lipopolysaccharide-induced acute lung injury in rats. Inflamm. Res.
14. Sarkar, M., Woodland, C., Koren G. & Einarson, A. Pregnancy outcome 2005; 54: 133“7.
following gestational exposure to azithromycin. BMC Pregnancy 38. Kao, S. C., Ting, C. K., Cheng, K. W. et al. Desflurane used in a patient with
Childbirth 2006; 6: 18. congenital insensitivity to pain with anhidrosis during septic shock. J. Chin.
15. Tollan, A., Sundsfjord, A. & Lindal, S. Perinatal listeriosis. Tiksskr. Nor. Med. Assoc. 2004; 67: 305“7.
Laegeforen. 1992; 112: 1451“2. 39. Lozano, F. S., Lopez-Novoa, J. M., Rodriguez, J. M. et al. Exogenous nitric
16. Nathan L., Twickler D. M., Peters M. T., Sanchez, P. J. & Wendel, G. D., Jr. oxide modulates the systemic inflammatory response and improves kidney
Fetal syphilis: correlation of sonographic findings and rabbit infectivity function after risk-situation abdominal aortic surgery. J. Vasc. Surg. 2005;
testing of amniotic fluid. J. Ultrasound Med. 1993; 12: 97“101. 42: 129“39.
17. Risser, W. L., Bortot, A. T., Benjamins, L. J. et al. The epidemiology of sexu- 40. Kruger, A. M. & Bhagwanjee, S. HIV/AIDS: impact on maternal mortality at
ally transmitted infections in adolescents. Semin. Pediatr. Infect. Dis. 2005; the Johannesburg Hospital, South Africa, 1995“2001. Int. J. Obstet. Anesth.
16: 160“7. 2003; 12: 164“8.
18. Ducloy, A. S., Buy, E., Ducloy, J. C. et al. Prediction of maternal infection 41. Centers for Disease Control and Prevention. Revised recommendations for
before performing epidural analgesia of labor. Anesthesiology 1993; 100: HIV testing of adults, adolescents, and pregnant women in health-care
A194. settings. MMWR 2006; 55: 1“18.
19. Stevens, D. L. Could nonsteroidal antiinflamatory drugs (NSAIDs) enhance 42. Quinn, T. C., Kline, R. L., Halsey, N. et al. Early diagnosis of perinatal HIV
the progression of bacterial infections to toxic shock syndrome? infection by detection of viral-specific Ig-A antibodies. J.A.M.A. 1991; 266:
(Hypothesis). Clin. Infect. Dis. 1995; 21: 977“80. 3439“42.
20. Wong, S. N., Tam, A. Y. & Yuen, K. Y. Campylobacter infection in the neo- 43. McIntyre, J. Prevention of mother-to-child transmission of HIV: treatment
nate: case report and review of the literature. Pediatr. Infect. Dis. J. 1990; 9: options. Expert Rev. Anti. Infect. Ther. 2005; 3: 971“80.
665“9. 44. Tibaldi, C., Tovo, P. A., Ziarati, N. et al. Asymptomatic women at high risk of
21. Rosenblatt, H. M., Song, L. Y., Nachman, S. A. et al. Pediatric Aids Clinical vertical HIV-1 transmission to their fetuses. Br. J. Obstet. Gynaecol. 1993;
Trials Group 377 Study Team. Tetanus immunity after diphtheria, tetanus 100: 334“7.
toxoids, and acellular pertussis vaccination in children with clinically stable 45. Weinberg, G. A. The dilemma of postnatal mother-to-child transmission of
HIV infection. J. Allergy Clin. Immunol. 2005; 116: 698“703. HIV: to breastfeed or not? Birth 2000; 27: 199“205.
22. Blanco, J. D., Gibbs, R. S. & Castaneda, Y. S. Bacteremia in obstetrics: clinical 46. Hartmann, S. U., Berlin, C. M. & Howett, M. K. Alternative modified infant-
course. Obstet. Gynecol. 1981; 58: 621“5. feeding practices to prevent postnatal transmission of human immunode-
23. Ledger, W. J. Bacterial infections complicating pregnancy. Clin. Obstet. ficiency virus type 1 through breast milk: past, present, and future. J. Hum.
Gynecol. 1978; 21: 455“75. Lact. 2006; 22: 75“88.
24. Khan, K. S., Wojdyla, D., Say, L., Gulmezoglu, A. M. & Van Look, P. F. WHO 47. Temmerman, M., Chomba, E. N., Ndinya-Achola, J. et al. Maternal human
analysis of causes of maternal death: a systemic review. Lancet 2006; 367: immunodeficiency virus-1 infection and pregnancy outcome. Obstet.
1066“74. Gynecol. 1994; 83: 495“501.
25. Yip, L., McClusky, J. & Sinclair, R. Immunological aspects of pregnancy. 48. Evron, S., Glezerrman, M., Harow, E., Sadan, O. & Ezri, T. Human immu-
Clin. Dermatol. 2006; 24: 84“7. nodeficiency virus: anesthetic and obstetric considerations. Anesth. Analg.
26. Gutierrez, G., Gentile, T., Miranda, S. & Margni R. A. Asymmetric antibodies: 2004; 98: 503“11.
a protective arm in pregnancy. Chem. Immunol. Allergy 2005; 89: 158“68. 49. Read, J. S. & Newell, M. K. Efficacy and safety of cesarean delivery for pre-
27. American College of Chest Physicians/Society of Critical Care Medicine vention of mother-to-child transmission of HIV-1. Cochrane Database Syst.
Consensus Conference: definitions for sepsis and organ failure and Rev. 2005; 19: CD005479.




337
5 Other disorders


50. Vogt, M. W., Witt, D. J., Craven, D. E. et al. Isolation of HTLV-III/LAV from 74. Roberts, S. W., Cox, S. M., Dax, J., Wendel, G. D., Jr. & Leveno, K. J. Genital
cervical secretions of women at risk for AIDS. Lancet 1986; 1: 525“7. herpes during pregnancy: no lesions, no cesarean. Obstet. Gynecol. 1995; 85:
51. Romero, R., Gomez, R., Araneda, H. et al. Cervical mucus inhibits microbial 261“4.
growth: a host defense mechanism to prevent ascending infection in preg- 75. Bader, A. M., Camann, W. R. & Datta, S. Anesthesia for cesarean delivery in
nant and non-pregnant women (SPO abstract). Am. J. Obstet. Gynecol. 1993; patients with herpes simples virus type-2 infections. Reg. Anesth. 1990; 15:
312: 57. 261“3.
52. Minkoff, H., Burns, D. N., Landesman, S. et al. The relationship of ruptured 76. Whitley, R. J. Herpes simples encephalitis: adolescents and adults. Antiviral
membranes to vertical transmission of human immunodeficiency virus. Res. 2006; 71: 141“8.
Am. J. Obstet. Gynecol. 1995; 173: 585“9. 77. Dupuis, O, Audibert, F., Fernandez, H. & Frydman, R. Herpes simples virus
53. Goedert, J. J., Duliege, A. M., Amos C. I., Felton, S. & Biggar, R. J. High risk of encephalitis in pregnancy. Obstet. Gynecol. 1999; 94: 810“12.
HIV-1 infection for first-born twins. Lancet 1991; 338: 1471“5. 78. Berger, S. A., Weinberg, M., Treves, T. et al. Herpes encephalitis during
54. American Academy of Neurology AIDS Task Force. Nomenclature and pregnancy: failure of acyclovir and adenine arabinoside to prevent neonatal
research case definitions for neurologic manifestations of human herpes. Isr. J. Med. Sci. 1986; 22: 41“4.
immunodeficiency virus-type 1 (HIV-1) infection. Neurology 1991; 41: 79. Crone, L. A., Conly, J. M., Clark, K. M. et al. Recurrent herpes simplex virus
778“85. labialis and the use of epidural morphine in obstetric patients. Anesth.
55. Leger, J. M., Bouche, P., Bolgert, F. et al. The spectrum of polyneuropa- Analg. 1988; 67: 318“23.
thies in patients infected with HIV. J. Neurol. Neurosurg. Psych. 1989; 52: 80. Valley, M. A., Bourke, D. L. & McKenzie, A. M. Recurrence of thoracic and
1369“74. labial herpes simplex virus infection in a patient receiving epidural fenta-
56. Marshall, D. W., Brey, R. L., Butzin, C. A. et al. CSF changes in a longitudinal nyl. Anesthesiology 1992; 76: 1056“7.
study of 124 neurologically normal HIV-1-infected U.S. Air force personnel. 81. Davies, P. W., Vallejo, M. C., Shannon, K.T, Amortegui, A. L. & Ramanathan,
J. Acquir. Immune Defic. Syndr. 1991; 4: 777“81. S. Oral herpes simplex reactivation after intrathecal morphine: a prospect-
57. Schwartz, D. M., Schwartz, T., Cooper, E. & Pullerits, J. Anaesthesia and the ive randomized trial in an obstetric population. Anesth. Analg. 2005; 100:
child with HIV infection. Can. J. Anaesth. 1991; 38: 626“33. 1472“6.
58. Miller, L. G., Galpern, W. R., Dunlap, K., Dinarello, C. A. & Turner, T. J. 82. Shen, C-Y., Chang, S. F., Yen, M. S. et al. Cytomegalovirus excretion
Interleukin-1 augments gamma-aminobutyric acid-A receptor function in in pregnant and non-pregnant women. J. Clin. Microbiol. 1993; 31:
brain. Mol. Pharmacol. 1991; 39: 105“8. 1635“6.
59. Fassoulaki, A. & Desmonts, J. M. Prolonged neuromuscular blockade after a 83. Fowler, K. B. Stagno, S., Pass, R. F. et al. The outcome of congenital cyto-
single bolus dose of vecuronium in patients with acquired immunodefi- megalovirus infection in relation to maternal antibody status. N. Engl.
ciency syndrome. Anesthesiology 1994; 80: 457“9. J. Med. 1992; 326: 663“7.
60. Parry, G. J. Peripheral neuropathies associated with human immunodefi- 84. Chow, S. S., Craig, M. E., Jacques, C. F. et al. Correlates of placental infection
ciency virus infection. Ann. Neurol. 1988; 23: S49“53. with cytomegalovirus, parvovirus B19 or human herpes virus 7. J. Med.
61. Till, M. & MacDonnell, K. B. Myopathy with human immunodeficiency Virol. 2006; 78: 747“56.
virus type 1 (HIV-1) infection: HIV-1 or zidovudine? Ann. Int. Med. 1990; 85. Grose, C., Meehan, T. & Weiner, C. P. Prenatal diagnosis of congenital
113: 492“4. cytomegalovirus infection by virus isolation after amniocentesis. Pediatr.
62. Shelton, M. J., O™Donnell, A. M. & Morse, G. D. Didanosine. Ann. Pharmacol. Infect. Dis. J. 1992; 11: 605“7.
Ther. 1992; 26: 660“70. 86. Huang, E. S., Alford, C. A., Reynolds, D. W., Stagno, S. & Pass, R. F. Molecular
63. Markovic, S. N., Knight, P. R. & Murasko, D. M. Inhibition of interferon epidemiology of cytomegalovirus infection in women and their infants.
stimulation of natural killer cell activity in mice anesthetized with N. Engl. J. Med. 1980; 303: 958“62.
halothane or isoflurane. Anesthesiology 1993; 78: 700“6. 87. Meier, J., Lienicke, U., Tschirch, E. et al. Human cytomegalovirus reactiva-
64. Squinto, S. P., Mondal, D., Block, A. L. & Prakash, O. Morphine-induced tion during lactation and mother-to-child transmission in preterm infants.
transactivation of HIV-1 LTR inhuman neuroblastoma cells. AIDS Res. J. Clin. Microbiol. 2005; 43: 1318“24.
Hum. Retroviruses 1990; 6: 1163“8. 88. Nigro, G., Adler, S. P., La Torre, R. et al. Passive immunization during
65. Bayer, B. M., Daussin, S., Hernandez, M. & Irvin, L. Morphine inhibition of pregnancy for congenital cytomegalovirus infection. N. Engl. J. Med. 2005;
lymphocyte activity is mediated by an opioid-dependent mechanism. 353: 1350“62.
Neuropharmacology 1990; 29: 369“74. 89. Berger, J. R. & Sabet, A. Infectious myelopathies. Semin. Neurol. 2002; 22:
66. Hu, S., Sheng, W. S., Lokensgard, J. R. & Peterson, P. K. Morphine potenti- 133“42.
ates HIV-1 gp120-indudced neuronal apoptosis. J. Infect. Dis. 2005; 191: 90. Doorbar, J. Molecular biology of human papillomavirus infection and cer-
886“9. vical cancer. Clin. Sci. (Lond.) 2006; 110: 525“41.
67. Wang, X., Tan, N., Douglas, S. D. et al. Morphine inhibits CD8 þ T cell- 91. Lowy, D. R. & Schiller, J. T. Prophylactic human papillomavirus vaccines.
mediated, noncytolytic, anti-HIV activity in latently infected immune J. Clin. Invest. 2006; 116: 1167“73.
cells. J. Leukoc. Biol. 2005; 78: 772“6. 92. Lehnen, H. Condylomata acuminata and mode of delivery. Z. Geburtshilfe
68. Pruett, S. B., Han, Y. C. & Fuchs, B. A. Morphine suppresses primary Perinatol. 1988; 192: 96“9.
humoral immune responses by a predominantly indirect mechanism. 93. Cook, T. A., Cohn, A. M., Brunschwig, J. P., Butel, J. S. & Rawls, W. E. Wart-
J. Pharmacol. Exp. Ther. 1992; 262: 923“8. viruses and laryngeal papillomas. Lancet 1973; 1: 782.
69. Sookoian, S. Liver disease and pregnancy: acute viral hepatitis. Ann. 94. Silverberg, M. J., Thorsen, P., Lindeberg, H., Grant, L. A. & Shah, K. V.
Hepatol. 2006; 5: 231“6. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent
70. Brown, J. & Corey, L. Maternal genital herpes and gender of offspring. Am. respiratory papillomatosis. Obstet. Gynecol. 2003; 101: 645“52.
J. Obstet. Gynecol. 1991; 165: 84. 95. Ferenczy, A., Bergeron, C. & Richart, R. M. Human papillomavirus DNA in
71. Koutsky, L. A., Stevens, C. E., Holmes, K. K. et al. Underdiagnosis of genital CO2 laser-generated plume of smoke and its consequences to the surgeon.
herpes by current clinical and viral-isolation procedures. N. Engl. J. Med. Obstet. Gynecol. 1990; 75: 114“18.
1992; 326: 1533“9. 96. Straus, S. E., Ostrove, J. M., Inchauspe, G. et al. NIH Conference: Varicella-
72. Malvy, D., Halioua, B., Lancon, F. et al. Epidemiology of genital herpes zoster virus infections. Biology, natural history, treatment, and prevention.
simplex virus infections in a community-based sample in France: results Ann. Intern. Med. 1988; 108: 221“37.
of the HERPIMAX study. Sex. Transm. Dis. 2005; 32: 499“505. 97. Balducci, J., Rodis, J. F., Rosengren, S. et al. Pregnancy outcome following
73. Cunningham, A. L., Lee, F. K., Ho, D. W. T. et al. Herpes simplex virus type 2 first-trimester varicella infection. Obstet. Gynecol. 1992; 79: 5“6.
antibody in patients attending antenatal or STD clinics. Med. J. Aust. 1993; 98. Brazin, S. A., Simkovich, J. W. & Johnson, W. T. Herpes zoster during preg-
158: 525“8. nancy. Obstet. Gynecol. 1979; 53: 175“81.




338
Chapter 18


99. Harris, R. E. & Rhoades, E. R. Varicella pneumonia complicating preg- 126. Martinez, V. P., Bellomo, C., San Juan, J. et al. Person-to-person transmis-
nancy: report of a case and review of literature. Obstet. Gynecol. 1965; 25: sion of Andes virus. Emerg. Infect. Dis. 2005; 11: 1848“53.
734“40. 127. Busch, M. P., Wright, D. J., Custer, B. et al. West Nile virus infections
100. Brunell, P. A. Varicella in pregnancy. The fetus, and the newborn: pro- projected from blood donor screening data, United States, 2003. Emerg.
blems in management. J. Infect. Dis. 1992; 166: S42“7. Infect. Dis. 2006; 12: 395“402.
101. Harger, J. H., Ernest, J. M., Thurnau, G. R. et al. Frequency of congenital 128. Scupski, D. W., Eglinton, G. S., Fine, A. D., Hayes, E. B. & O™Leary, D. R.
varicella syndrome in a prospective cohort of 347 pregnant women. Obstet. West Nile virus during pregnancy: a case study of early second trimester
Gynecol. 2002; 100: 260“5. maternal infection. Fetal Diagn. Ther. 2006; 21: 293“5.
102. Brown, N. W., Parsons, A. P. & Kam, P. C. Anesthetic considerations in a 129. Paisley, J. E., Hinckley, A. F., O™Leary, D. R. et al. West Nile virus infection
parturient with varicella presenting for Caesarean section. Anaesthesia among pregnant women in a northern Colorado community, 2003 to 2004.
2003; 58: 1092“5. Pediatrics 2006; 17: 814“20.
103. Harger, J. H., Ernest, J. M., Thurnau, G. R. et al. Risk factors and outcomes of 130. Alpert, S. G., Fergerson, J. & Noel, L. P. Intrauterine West Nile virus:
varicella viral pneumonia in pregnant women. J. Infect. Dis. 2002; 185: 422“7. ocular and systemic findings. Am. J. Ophthalmol. 2003; 136: 733“5.
104. Advances in global measles control and elimination: summary of the 131. Fleischauer, A. T., Kile, J. C., Davidson, M. et al. Evaluation of human-to-
1997 international meeting. M. M. W. R. Recomm. Rep. 1998; 47: 1“23. human transmission of monkeypox from infected patients to health care
105. Strebel, P., Cochi, S., Grabowsky, M. et al. The unfinished measles immu- workers. Clin. Infect. Dis. 2005; 40: 689“94.
nization agenda. J. Infect. Dis. 2003; 187: S1“7. 132. Learned, L. A., Reynolds, M. G., Wassa, D. W. et al. Extended interhuman
106. Eberhart-Phillips, J. E., Frederick, P. D., Baron, R. C. & Mascola, L. Measles transmission of monkeypox in a hospital community in the Republic of
in pregnancy: a descriptive study of 58 cases. Obstet. Gynecol. 1993; 82: the Congo, 2003. Am. J. Trop. Med. Hyg. 2005; 73: 428“34.
797“801. 133. Yudin, M. H., Steele D. M., Sgro, M. D. et al. Severe acute respiratory syn-
107. Chiba, M. E., Saito, M., Suzuki, N., Honda, Y. & Yaegashi, N. Measles drome in pregnancy Obstet. Gynecol. 2005; 105: 124“7.
infection in pregnancy. J. Infect. 2003; 47: 40“4. 134. Wong, S. F., Chow, K. M., Leung, T. N. et al. Pregnancy and perinatal out-
108. Signore, C. Rubeola. Prim. Care Update Ob. Gyn. 2001; 8: 138“40. comes of women with severe acute respiratory syndrome. Am. J. Obstet.
109. Bembenek, A. Could the fetus™ exposure to influenza increase the risk of Gynecol. 2004; 191: 292“7.
schizophrenia in adult life? Psychiatr. Pol. 2005; 39: 271“83. 135. Lam, C. M., Wong, S. F., Leung, T. N. et al. A case-controlled study compar-
110. Smith, G. J., Naipospos, T. S., Nguyen, T. D. et al. Evolution and adaptation ing clinical course and outcomes of pregnant and non-pregnant women
of H5N1 influenza virus in avian and human hosts in Indonesia and with severe acute respiratory syndrome. B.J.O.G. 2004; 111: 771“4.
Vietnam. Virology 2006; 350: 258“68. 136. Owolabi, T. & Kwolek, S. Managing obstetrical patients during severe acute
111. Rodis, J. F., Quinn, D. L., Gary, G. W., Jr. et al. Management and outcomes respiratory syndrome outbreak. J. Obstet. Gynaecol. Can. 2004; 26: 35“41.
of pregnancies complicated by human B19 parvovirus infection: a pro- 137. Guzman, M. G. & Kouri, G. Dengue and dengue hemorrhagic fever in the
spective study. Am. J. Obstet. Gynecol. 1990; 163: 1168“71. Americas: lessons and challenges. J. Clin. Virol. 2003; 27: 1“13.
112. Ergaz, Z. & Ornoy, A. Parvovirus B19 in pregnancy. Reprod. Toxicol. 2006; 138. Stephenson, J. R. Understanding dengue pathogenesis: implications for
21: 421“35. vaccine design. Bull. World Health Organ. 2005; 83: 308“14.
113. Mead, B. P. Parvovirus B19 infection and pregnancy. Contemp. Obstet. 139. Takada, A., Feldmann, H., Ksiazek, T. G. & Kawaoka, Y. Antibody-depen-
Gynecol. 1989; 9: 56. dent enhancement of Ebola virus infection. J. Virol. 2003; 77: 7539“44.
114. Carlson, D. E., Platt, L. D., Medearis, A. L. & Horenstein, J. Prognostic 140. Morens, D. M. Antibody-dependent enhancement of infection and the
indicators of the resolution of nonimmune hydrops fetalis and survival pathogenesis of viral disease. Clin. Infect. Dis. 1994; 19: 500“12.
of the fetus. Am. J. Obstet. Gynecol. 1990; 163: 1785“7. 141. Rodriguez-Figueroa, L., Rigau-Perez, J. G., Suarez, E. L. & Reiter, P. Risk
115. Simpson, J. L., Elias, S., Morgan, C. D. et al. Does unexplained second- factors for dengue infection during an outbreak in Yanes, Puerto Rico in
trimester (15 to 20 weeks™ gestation) maternal serum a-fetoprotein eleva- 1991. Am. J. Trop. Med. Hyg. 1995; 52: 496“502.
tion presage adverse perinatal outcome? Pitfalls and preliminary studies 142. Hoeck, P. A., Ramberg, F. B., Merrill, S. A., Moll, C. & Hagedorn, H. H.
with late second- and third- trimester maternal serum a-fetoprotein. Am. Population and parity levels of Aedes aegypti collected in Tucson. J.
J. Obstet. Gynecol. 1991; 164: 829“36. Vector Ecol. 2003; 28: 65“73.
´
116. Peters, M. & Nicolaides, K. Cordocentesis for the diagnosis and treatment 143. Secretaria do Estado da Saude “ Centro de Vigilˆ ncia Epidemiol´ gica
a o
of human fetal parvovirus infection. Obstet. Gynecol. 1990; 75: 501“4. ˜˜Prof. Alexandre Vranjac™™. Manual Sobre Dengue. 1994.
117. Naides, S. J. & Weiner, C. P. Antenatal diagnosis and palliative treatment of 144. Liam, C. K., Yap, B. H. & Lam, S. K. Dengue fever complicated by pulmon-
nonimmune hydrops fetalis secondary to fetal parvovirus B19 infection. ary haemorrhage manifesting as haemoptysis. J. Trop. Med. Hyg. 1993; 96:
Prenat. Diagn. 1989; 9: 105“14. 197“200.
118. Humphrey, W., Magoon, M. & O™Shaughnessy, R. Severe non-immune 145. Halstead, S. B., Porterfield, J. S. & O™Rourke, E. J. Enhancement of dengue
hydrops secondary to parvovirus B19 infection: spontaneous reversal in virus infection in monocytes by flavivirus antisera. Am. J. Trop. Med. Hyg.
utero and survival of a term infant. Obstet. Gynecol. 1991; 78: 900“2. 1980; 29: 638“42.
119. Hwa, H. L., Shyu, M. K., Lee, C. N. et al. Prenatal diagnosis of congenital 146. Chang, D. M. & Shaio, M. F. Production of interleukin-1 (IL-1) and IL-1
rubella in Tawain. Obstet. Gynecol. 1994; 84: 415“19. inhibitor by human monocytes exposed to dengue virus. J. Infect. Dis.
120. Gyorkos, T. W., Beliveau, C., Rahme, E. et al. High rubella seronegativity in 1994; 170: 811“17.
daycare educators. Clin. Invest. Med. 2005; 28: 105“11. 147. Chungue, E., Burucoa, C., Boutin, J. P. et al. Dengue 1 epidemic in French
121. Ueno, Y. Rubella arthritis. An outbreak in Kyoto. J. Rheumatol. 1994; 21: Polynesia, 1988“1989: surveillance and clinical, epidemiological, virologi-
874“6. cal and serological findings in 1752 documented clinical cases. Trans.
122. Ksiazek, T. G., Peters, C. J., Rollin, P. E. et al. Identification of a new North Royal Soc. Trop. Med. Hyg. 1992; 86: 193“7.
American hantavirus that causes acute pulmonary insufficiency. Am. 148. Chong, K. Y. & Lin, K. C. A preliminary report of the fetal effects of dengue
J. Trop. Med. Hyg. 1995; 52: 117“23. infection in pregnancy. Gaoxiong Yi Xue Ke Xue Za Zhi 1989; 5: 31“4.
123. Ma, R. M., Xiao, H., Jing, X. T. & Lao, T. T. Hemorrhagic fever with renal 149. Carles, G., Talarmin, A., Peneau, C. & Bertsch, M. Dengue fever and
syndrome presenting with intrauterine fetal death. A case report. pregnancy. A study of 38 cases in French Guiana. J. Gynecol. Obstet. Biol.
J. Reprod. Med. 2003; 48: 661“4. Reprod. 2000; 29: 758“62.
124. Gilson, G. J., Maciulla, J. A., Nevils, B. G. et al. Hantavirus pulmonary syn- 150. Restrepo, B. N., Isaza, D. M., Salazar, C. L. et al. Prenatal and postnatal
drome complicating pregnancy. Am. J. Obstet. Gynecol. 1994; 171: 550“4. effects of dengue infection during pregnancy. Biomedica 2003; 23: 416“23.
125. Howard, M. J., Doyle, T. J., Koster, F. T. et al. Hantavirus pulmonary syn- 151. Costa, S. M., Freire, M. S. & Alves, A. M. DNA vaccine against the non-
drome in pregnancy. Clin. Infect. Dis. 1999; 29: 1538“44. structural 1 protein (NS1) of dengue 2 virus. Vaccine 2006; 24: 4562“4.




339
5 Other disorders


152. Watanaveeradej, V., Endy, T. P., Samakoses, R. et al. Transplacentally 175. Steketee, R. W., Breman, J. G., Paluku, K. M. et al. Malaria infection in
transferred maternal-infant antibodies to dengue virus. Am. J. Trop. Med. pregnant women in Zaire: the effects and potential for intervention. Ann.
Hyg. 2003; 69: 123“8. Trop. Med. Parasitol. 1988; 82: 113“20.
153. Chye, J. K., Lim, C. T., Ng, K. B. et al. Vertical transmission of dengue. Clin. 176. Nosten, F., Vincenti, M., Simpson, J. et al. The effects of mefloquine
Infect. Dis. 1997; 25: 1374“7. treatment in pregnancy. Clin. Infect. Dis. 1999; 28: 808“15.
154. Ferreira, M. L., Cavalcanti, C. G., Coelho, C. A. & Mesquita, S. D. 177. McGready, R., Cho, T., Cho, J. J. et al. Artemisinin derivatives in the treat-
Neurological manifestations of dengue: study of 41 cases. Arq. ment of falciparum malaria in pregnancy. Trans. R. Soc. Trop. Med. Hyg.
Neuropsiquiatr. 2005; 63: 488“93. 1998; 92: 430“3.
155. Cetron, M. S., Marfin, A. A., Julian, K. G. et al. Yellow fever vaccine. 178. Centers for Disease Control and Prevention (CDC). Availability and use of
Recommendations of the Advisory Committee on Immunization parenteral quinidine gluconate for severe or complicated malaria. Morb.
Practices (ACIP), 2002. M.M.W.R. Recomm. Rep. 2002; 51: 1“11. Mortal. Wkly. Rep. 2000; 49: 1138“40.
156. De Cock, K. M., Monath, T. P., Nasidi, A. et al. Epidemic yellow fever in 179. Zucker, J. R. & Campbell, C. C. Malaria. Principles of prevention and treat-
eastern Nigeria. Lancet 1988; 1: 630“3. ment. Infect. Dis. Clin. North Am. 1993; 7: 547“67.
157. Russell, M. N., Cetron, M. S. & Eidex, R B. The U. S.-certified yellow fever 180. Powell, V. I. & Grima, K. Exchange transfusion for malaria and Babesia
vaccination center registry: a tool for travelers, state health departments, infection. Transfus. Med. Rev. 2002; 16: 239“50.
and vaccine providers. J. Travel Med. 2006; 13: 48“9. 181. Njoku, A. K. Tuberculosis: current trends in diagnosis and treatment.
158. Nishioka Sde, A., Nunes-Araujo, F. R., Pires, W. P., Silva, F. A. & Costa, H. L. Niger. J. Clin. Pract. 2005; 8: 118“24.
Yellow fever vaccination during pregnancy and spontaneous abortion: a 182. Seidler, A., Nienhaus, A. & Diel, R. Review of epidemiological studies on
case-control study. Trop. Med. Int. Health 1998; 3: 29“33. the occupational risk of tuberculosis in low-incidence areas. Respiration
159. Tsai, T. F., Paul, R., Lynberg, M. C. & Letson, G. W. Congenital yellow fever 2005; 72: 431“46.
infections after immunization in pregnancy. J. Infect. Dis. 1993; 168: 183. Reider, H. L., Cauthen, G. M., Comstock, G. W. & Snider, D. E. Epidemiology
1520“3. of tuberculosis in the United States. Epidemiol. Rev. 1989; 11: 79“98.
160. Suzano, C. E., Amaral, E., Sato, H. K. & Papaiordanou, P. M. Campinas 184. Centers for Disease Control and Prevention (CDC). Trends in tuberculosis “
group on yellow fever immunization during pregnancy. The effects of United States, 2005. Morb. Mortal. Wkly. Rep. 2006; 55: 305“8.
yellow fever immunization (17DD) inadvertently used in early pregnancy 185. Ong, A., Rudoy, I., Gonzalez, L. C. et al. Tuberculosis in healthcare workers:
during a mass campaign in Brazil. Vaccine 2005; 24: 1421“6. a molecular epidemiologic study in San Francisco. Infect. Control Hosp.
161. Centers for Disease Control and Prevention. Leptospirosis. www.cdc.gov/ Epidemiol. 2006; 27: 453“8.
ncidod/dbmd/diseaseinfo/lepto spirosis_g.htm. 2005 Oct 12. Accessed 186. Sharma, S. K. & Mohan, A. Scientific basis of directly observed treatment,
June 2006. short-course (DOTS). J. Indian Med. Assoc. 2003; 101: 157“8.
162. Rodriguez-Gonzalez, I., Fillonneau, C., Blanchet, B. et al. Efficacy of 187. Centers for Disease Control and Prevention (CDC). National Center for
Spirolept vaccine against human leptospirosis as estimated by passive HIV, STD, and TB Prevention. Tuberculosis and Pregnancy Fact Sheet.
protection of laboratory rodents. Med. Mal. Infect. 2004; 34: 196“200. Accessed at www.cdc.gov/nchstp/tb/pubs/tbfactsheets/250160.htm.
163. John, T. J. The prevention and control of human leptospirosis. J. Postgrad. Updated April 2006.
Med. 2005; 51: 205“9. 188. Steichen, O., Martinez-Almoyna, L. & De Broucker, T. Isoniazid induced
164. Doudier, B., Garcia, S., Quennee, V., Jarno, P. & Brouqui, P. Prognostic neuropathy: consider prevention. Rev. Mal. Respir. 2005; 23: 157“60.
factors associated with severe leptospirosis. Clin. Microbiol. Infect. 2006; 189. Lee, G. S., Kim, S. J., Park, I. Y., Shin, J. C. & Kim, S. P. Tuberculous perito-
12: 299“300. nitis in pregnancy. J. Obstet. Gynaecol. Res. 2005; 31: 436“8.
165. Tramoni, G., Clement, H. J., Lopez, F. & Viale, J. P. An unusual case of post 190. Jutte, P. & Van Loenhout-Rooyackers, J. Routine surgery in addition to
partum haemorrhage: leptospirosis infection. Ann. Fr. Anesth. Reanim. chemotherapy for treating spinal tuberculosis. Cochrane Database Syst.
2003; 22: 363“5. Rev. 2006; 25: CD004532.
166. Centers for Disease Control and Prevention (CDC). Malaria. 191. Hassoun, A., Jacquette, G., Huang, A., Anderson, A. & Smith, M. A. Female
www.cdc.gov/malaria/facts.htm. May 4, 2004. genital tuberculosis: uncommon presentation of tuberculosis in the
167. White, N. J., Chapman, D. & Watt, G. The effects of multiplication and United States. Am. J. Med. 2005; 118: 1295“6.
synchronicity on the vascular distribution of parasites in falciparum 192. Morau, E. L., Lotthe, A. A., Morau, D. Y. et al. Bifocal tuberculosis high-
malaria. Trans. Royal Soc. Trop. Med. Hyg. 1992; 86: 590“7. lighted by obstetric combined spinal“epidural analgesia. Anesthesiology
168. Brown, A. E., Herrington, D. A., Webster, H. K. et al. Urinary neopterin in 2005; 103: 445“6.
volunteers experimentally infected with Plasmodium falciparum. Trans. 193. Ray, V. & Foy, J. Paraspinal abscess associated with epidural in labour.
Royal Soc. Trop. Med. Hyg. 1992; 86: 134“6. Anaesth. Intensive Care 1998; 26: 424“6.
169. White, N. J., Warrell, D. A., Chanthavanish, P. et al. Severe hypoglycemia and 194. Lee, B. B., Ngan Kee, W. D. & Griffith, J. F. Vertebral osteomyelitis and
hyperinsulinemia in falciparum malaria. N. Engl. J. Med. 1983; 309: 61“6. psoas muscle abscess occurring after obstetric epidural anesthesia. Reg.
170. Davis, T. M. E., Garcia-Webb, P., Fu, L. C. et al. Antioxidant vitamins in Anesth. Pain Med. 2002; 27: 220“4
acute malaria. Trans. Royal Soc. Trop. Med. Hyg. 1994; 87: 596“7. 195. Centers for Disease Control and Prevention (CDC). Division of Parasitic
171. Nosten, F., Ter Kuile, F., Thwai, K. L., Maelankirri, L. & White, N. J. Diseases. Schistosomiasis Fact Sheet. Accessed at www.cdc.gov/ncidod/
Spiramycin does not potentiate quinine treatment of falciparum malaria dpd/parasites/schistosomiasis/factsht_schistosomiasis.htm Updated
in pregnancy. Trans. Royal Soc. Trop. Med. Hyg. 1993; 87: 305“6. August 27, 2004.
172. Na Bangchang, K., Davis, T. M. E., Looareesuwan, S. et al. Mefloquine 196. Neves, J., Raso, P., Pinto, D. M., da Silva, S. P. & Alvarenga, R. J. Ischaemic
pharmacokinetics in pregnant women with acute falciparum malaria. colitis (necrotizing colitis, pseudomembranous colitis) in acute shistoso-
Trans. Royal Soc. Trop. Med. Hyg. 1994; 88: 321“3. miasis mansoni: report of two cases. Trans. Royal Soc. Trop. Med. Hyg.
173. Okoyeh, J. N., Lege-Oguntoye, L., Emembolu, J. O., Sarki, U. & Slotboom, 1993; 87: 449“52.
A. B. Sensitivity of Plasmodium falciparum to pyrimethamine in vivo and 197. Ajanga, A., Lwambo, N. J., Blair, L. et al. Schistosoma mansoni in pregnancy
to sulphadoxine/pyrimethamine combination in vitro in pregnant women and associations with anaemia in northwest Tanzania. Trans. Royal Soc.
of northern Nigeria. J. Trop. Med. Hyg. 1993; 96: 56“9. Trop. Med. Hyg. 2006; 100: 59“63.
174. Mvondo, J. L., James, M. A., Sulzer, A. J. & Campbell, C. C. Malaria and 198. Giboda, M. & Smith, J. M. Schistosoma mansoni eggs as a target for prazi-
pregnancy in Cameroonian women. Naturally acquired antibody quantel: efficacy of oral application in mice. J. Trop. Med. Hyg. 1994; 97:
responses to asexual blood-stage antigens and the circumsporozoite pro- 98“102.
tein of Plasmodium falciparum. Trans. Royal Soc. Trop. Med. Hyg. 1992; 199. Domingues, A. L., Lima, A. R. F., Dias, H. S., Leao, G. C. & Coutinho, A.
86: 486“90. An ultrasonographic study of liver fibrosis in patients infected with




340
Chapter 18


Schistosoma mansoni in northeast Brazil. Trans. Royal Soc. Trop. Med. Hyg. 224. Roso Nde, C., Abrao, J. & Alves Neto, J. Etomidate and vecuronium in
1993; 87: 555“8. induction of anesthesia of chronic Chagas™ cardiopathy. Rev. Soc. Bras.
200. Adam, I., Elwasila, E. & Homeida, M. Praziquantel for the treatment of Med. Trop. 1999; 32: 41“6.
Schistosomiasis mansoni during pregnancy. Ann. Trop. Med. Parasitol. 225. Lessnau, K. D. & Arjomand, F. Psittacosis. www.eMedicine.com/med/
2005; 99: 37“40. topic1951.htm. Last updated May 2, 2006.
201. Olds, G. R. Administration of praziquantel to pregnant and lactating 226. Ghermam, R. B., Leventis, L. L. & Miller, R. Chlamydial psittacosis during
women. Acta Trop. 2003; 86: 185“95. pregnancy: a case report. Obstet. Gynecol. 1995; 86: 648“50.
202. Shi, Y. E., Johansen, M. V., Li, F. R. et al. An epidemiological investigation of 227. Chang, Y. T., Lin, J. Y. & Huang, Y. S. Typhoid colonic perforation in child-
congenital Schistosoma japonicum transmission in Hubei Province, PR hood: a ten-year experience. World J. Surg. 2006; 30: 242“7.
China. Southeast Asian J. Trop. Med. Public Health 2001; 32: 323“5. 228. Rodriguez, R. E., Valero, V. & Watanakunakorn, C. Salmonella focal intra-
203. Centers for Disease Control and Prevention (CDC). Division of Vector- cranial infections: review of the world literature (1884“1984) and report of
Borne Infectious Diseases. Plague. www.cdc.gov/ncidod/dvbid/plague/ an unusual case. Rev. Infect. Dis. 1986; 8: 31“41.
facts.htm. Page last reviewed March 20, 2005. 229. van de Wetering, J., Visser, L. G., van Buchem, M. A. & van der Hoeven, J. G.
204. The black death: Bubonic plague. www.themiddleages.net/plague.html. A case of typhoid fever complicated by unexpected cerebral edema. Clin.
205. Nair, G. B., Ramamurthy, T., Bhattacharaya, S. K. et al. Spread of vibrio Inf. Dis. 1995; 21: 1057“8.
cholerae O139 Bengal in India. J. Inf. Dis. 1994; 169: 1029“34. 230. Acharya, G., Butler, T., Ho, M. et al. Treatment of typhoid fever: random-
206. Echeverria, P., Hoge, C. W., Bodhidatta, L. et al. Molecular characterization ized trial of a three-day course of ceftriaxone versus a fourteen-day course
of vibrio cholerae O139 isolates from Asia. Am. J. Trop. Hyg. 1995; 52: of chloramphenicol. Am. J. Trop. Med. Hyg. 1995; 52: 162“5.
124“7. 231. Roll, C., Schmid, E. N., Menken, U. & Hanssler, L. Fatal Salmonella enter-
207. World Health Organization. Cholera. Fact sheet no. 107. Revised March itidis sepsis acquired prenatally in a premature infant. Obstet. Gynecol.
2000. 1996; 88: 692“3.
208. Huq, A., Parveen, S., Qadri, F., Sack, D. A. & Colwell, R. R. Comparison of 232. Roizen, N., Swisher, C. N., Stein, M. A. et al. Neurologic and developmental
vibrio cholarea serotype O1 strains isolated from patients and the aquatic outcome in treated congenital toxoplasmosis. Pediatrics 1995; 95: 11“20.
environment. J. Trop. Med. Hyg. 1993; 96: 86“92. 233. Figueiro-Filho, E. A., Duarte, G., El-Beitune, P., Quintana, S. M. & Maia,
209. Mujica, O. J., Quick, R. E., Palacios, A. M. et al. Epidemic cholera in the T. L. Visceral leishmaniasis (kala-azar) and pregnancy. Infect. Dis. Obstet.
Amazon: the role of produce in disease risk and prevention. J. Infect. Dis. Gynecol. 2004; 12: 31“40.
1994; 169: 1381“4. 234. Meinecke, C. K., Schottelius, J., Oskam, L. & Fleischer, B. Congenital trans-
210. Colwell, R. R., Hasan, J. A., Huq, A. et al. Development and evaluation of a mission of visceral leishmaniasis (Kala Azar) from an asymptomatic
rapid, simple, sensitive, monoclonal antibody-based coagglutination test mother to her child. Pediatrics 1999; 105: e65.
for direct detection of vibrio cholarea O1. F.E.M.S. Microbiol. Let. 1992; 76: 235. Pagliano, P., Carannante, N., Rossi, M. et al. Visceral leishmaniasis in
215“19. pregnancy: a case series and a systematic review of the literature. J.
211. Islam, M. S., Hasan, M. K., Miah, M. A. et al. Specificity of Cholera Screen” Antimicrob. Chemother. 2005; 55: 229“33.
test during an epidemic of cholera-like disease due to Vibrio cholerae O 236. Woldehiwet, Z. Q fever (coxiellosis): epidemiology and pathogenesis. Res.
139 synonym, Bengal. Trans. Royal Soc. Trop. Med. Hyg. 1994; 88: 424“5. Vet. Sci. 2004; 77: 93“100.
212. Saha, D., Karim, M. M., Khan, W. A. et al. Single-dose azithromycin for the 237. Raoult, D., Fenollar, F. & Stein, A. Q fever during pregnancy: diagnosis,
treatment of cholera in adults. N. Engl. J. Med. 2006; 354: 2452“62. treatment and follow-up. Arch. Intern. Med. 2002; 162: 701“4.
213. Guevart, E., Solle, J., Mouangue, A. et al. Antibiotic susceptibility of Vibrio 238. Centers for Disease Control and Prevention. Update: management of
cholerae 01: evolution after prolonged curative and preventive use during patients with suspected viral hemorrhagic fever “ United States. J.A.M.A.
the 2004 cholera epidemics in Douala (Cameroon). Med. Mal. Infect. 2006; 1995; 274: 374“5.
36: 329“34. 239. Centers for Disease Control and Prevention. Update: outbreak of Ebola
214. Lucas, M. E., Deen, J. L., von Seidlein, L. et al. Effectiveness of mass oral viral hemorrhagic fever “ Zaire, 1995. J. A. M.A. 1995; 274: 373“4.
cholera vaccination in Beira, Mozambique. N. Engl. J. Med. 2005; 352: 240. Boumandouki, P., Formenty, P., Epelboin, A. et al. Clinical management of
757“67. patients and deceased during the Ebola outbreak from October to
215. Hill, D. R., Ford, L. & Lalloo, D. G. Oral cholera vaccines: use in clinical December 2003 in Republic of Congo. Bull. Soc. Pathol. Exot. 2005; 98:
practice. Lancet Infect. Dis. 2006; 6: 361“73. 218“23.
216. Guerrant, R. L. Cholera “ still teaching hard lessons. N. Engl. J. Med. 2006; 241. Eng, R. H. K. & Seligman, S. J. Lumbar puncture-induced meningitis.
354: 2500“2. J.A.M.A. 1981; 245: 1456“9.
217. James, T. N., Rossi, M. A. & Yamamoto, S. Postmortem studies of the 242. Smith, K. M., Deddish, R. B. & Ogata, E. S. Meningitis associated with serial
intertruncal plexus and cardiac conduction system from patients with lumbar punctures and post-hemorrhagic hydrocephalus. J. Pediatrics
Chagas disease who died suddenly. Prog. Cardiovasc. Dis. 2005; 47: 1986; 109: 1057“60.
258“75. 243. Teele, D. W., Dashefsky, B., Rakusan, T. & Klein, J. O. Meningitis after
218. Rassi, A., Amato Neto, V., Rassi, G. G. et al. A retrospective search for lumbar puncture in children with bacteremia. N. Engl. J. Med. 1981; 305:
maternal transmission of Chagas infection from patients in the chronic 1079“81.
phase. Rev. Soc. Bras. Med. Trop. 2004; 37: 485“9. 244. Scott, D. B. & Hibbard, B. M. Serious non-fatal complications associated
219. Azogue, E. Women and congenital Chagas™ disease in Santa Cruz, Bolivia: with extradural block in obstetric practice. Br. J. Anaesth. 1990; 64:
epidemiological and sociocultural aspects. Soc. Sci. Med. 1993; 37: 503“11. 537“41.
220. Gilson, G. J., Harner, K. A., Abrams, J., Izquierdo, L. A. & Curet, L. B. Chagas 245. Hlavin, M. L., Kaminski, H. J., Ross, J. S. & Ganz, E. Spinal epidural abscess:
disease in pregnancy. Obstet. Gynecol. 1995; 86: 646“7. a ten-year perspective. Neurosurgery 1990; 27: 177“84.
221. Torrico, F., Vega, C. A., Suarez, E. et al. Are maternal re-infections with 246. Schreiner, E. J., Lipson, S. F., Bromage, P. R. & Camporesi, E. M.
Trypanosoma cruzi associated with higher morbidity and mortality of Neurological complications following general anaesthesia. Three cases
congenital Chagas disease? Trop. Med. Int. Health 2006; 11: 628“35. of major paralysis. Anaesthesia 1983; 38: 226“9.
222. da Cunha, A. B. Chagas™ disease and the involvement of the autonomic 247. Jakobsen, K. B., Christensen, M. K. & Carlsson, P. S. Extradural anaesthesia
nervous system. Rev. Port. Cardiol. 2003; 22: 813“24. for repeated surgical treatment in the presence of infection. Br. J. Anaesth
223. Cardinalli-Neto, A., Greco, O. T. & Bestetti, R. B. Automatic implantable 1995; 75: 536“40.
cardioverter-defibrillators in Chagas™ heart disease patients with malig- 248. Ngan Kee, W. D., Jones, M. R., Thomas, P. & Worth, R. J. Extradural abscess

<< . .

 67
( 87)



. . >>

Copyright Design by: Sunlight webdesign